Commercial Physical & Biological Research stocks: intrinsic value, ROIC & growth
15 U.S. commercial physical & biological research companies with at least three years of SEC filings, ranked by size. 4 of the 9 with a current price trade below their Graham intrinsic value. The median company earned a 11.7% average return on invested capital and grew revenue 10.2% a year.
Updated October 18, 2026
15companies
4below Graham value
11.7%median 10-yr ROIC
10.2%median revenue CAGR
Most undervalued commercial physical & biological research stocks
| Ticker | Company | Upside | Price | Graham value | Price vs value | Market cap | ROIC (10y) | Revenue CAGR |
|---|---|---|---|---|---|---|---|---|
| INCY | Incyte | +88% | $113.07 | $212.91 | 47% below | $22.7B | 11.7% | 18.6% |
Highest-ROIC commercial physical & biological research stocks
| Ticker | Company | 10-yr ROIC | Price | Graham value | Price vs value | Market cap | ROIC (10y) | Revenue CAGR |
|---|---|---|---|---|---|---|---|---|
| MEDP | Medpace Holdings, Inc. | 53.8% | $618.47 | $507.54 | 22% above | $18.3B | 53.8% | 22.0% |
| NRC | NRC HEALTH | 47.7% | $20.15 | $1,056.86 | 98% below | $451.3M | 47.7% | 2.6% |
| INCY | Incyte | 11.7% | $113.07 | $212.91 | 47% below | $22.7B | 11.7% | 18.6% |
| CRL | Charles River Laboratories | 7.9% | $300.15 | $4.23 | 6996% above | $14.9B | 7.9% | 10.2% |
| IQV | IQVIA | 6.1% | $266.90 | $260.41 | 2% above | $46.3B | 6.1% | 10.2% |
All commercial physical & biological research stocks
| Ticker | Company | Price | Graham value | Price vs value | Market cap | ROIC (10y) | Revenue CAGR |
|---|---|---|---|---|---|---|---|
| IQV | IQVIA | $266.90 | $260.41 | 2% above | $46.3B | 6.1% | 10.2% |
| INCY | Incyte | $113.07 | $212.91 | 47% below | $22.7B | 11.7% | 18.6% |
| MEDP | Medpace Holdings, Inc. | $618.47 | $507.54 | 22% above | $18.3B | 53.8% | 22.0% |
| CRL | Charles River Laboratories | $300.15 | $4.23 | 6996% above | $14.9B | 7.9% | 10.2% |
| ABSI | Absci Corp | $8.25 | $4.59 | 80% above | $1.1B | 52.6% | -7.4% |
| NOTV | Inotiv, Inc. | — | $6.31 | — | — | -12.1% | 43.1% |
| OABI | OmniAb, Inc. | $4.59 | $9.97 | 54% below | $521.6M | -116.8% | -14.4% |
| NRC | NRC HEALTH | $20.15 | $1,056.86 | 98% below | $451.3M | 47.7% | 2.6% |
| ONMD | OneMedNet Corp | $4.51 | $0.51 | 784% above | $200.9M | 79.9% | 5.6% |
| MXCT | MAXCYTE, INC. | $1.30 | — | — | $138.4M | -36.1% | 7.9% |
| FOXO | FOXO TECHNOLOGIES INC. | $0.11 | — | — | — | 1114.8% | 241.7% |
| BIAF | bioAffinity Technologies, Inc. | $3.73 | — | — | $6.4M | -189.8% | 986.6% |
| ISPC | iSpecimen Inc. | $0.92 | $82.03 | 99% below | $4.2M | 61.7% | -25.1% |
| BUDZ | WEED, INC. | $0.02 | — | — | $2.7M | -1757.6% | — |
| CBIH | Cannabis Bioscience International Holdings, Inc. | $0.00 | — | — | $1.6M | 149.7% | -2.2% |
Stock lists
Undervalued Stocks Below Graham Intrinsic Value
Highest ROIC Stocks (10-Year Average)
Highest Free Cash Flow Yield Stocks
Fastest-Growing Stocks by 10-Year Revenue